Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 11;14(20):4977.
doi: 10.3390/cancers14204977.

A North-West London Experience of the Impact of Treatment Related Toxicity on Clinical Outcomes of Elderly Patients with Germ Cell Tumors

Anand Sharma  1 , Laura Morrison  1 , Marina Milic  1 , Aruni Ghose  1 , Andrew Gogbashian  2 , Nikhil Vasdev  3   4 , Samita Agarwal  5 , Ben Pullar  3 , Gordon Rustin  1
Affiliations

A North-West London Experience of the Impact of Treatment Related Toxicity on Clinical Outcomes of Elderly Patients with Germ Cell Tumors

Anand Sharma et al. Cancers (Basel). .

Abstract

Background/Aim: The occurrence of germ cell tumour (GCT) in the elderly is rare, with scarce data available. The aim of this study was to understand the clinical outcomes of patients with GCT in patients aged > 45 years. Materials and Methods: A retrospective study was conducted in a large tertiary cancer centre in north-west London. Between 1 January 2003 and 31 March 2022, 108 cases of GCT in men aged > 45 years were identified and treated at the Mount Vernon Cancer Centre. The median age at diagnosis was 54 years (range = 45−70 years). Results: The 5-year survival rate of all patients was 96%, and the toxicity profile was similar to the younger age group. Conclusion: Older patients with GCT are able to tolerate chemotherapy; however, care must be taken to prevent life-threatening complications using appropriate dose modification.

Keywords: chemotherapy; clinical outcomes; complications; elderly; testicular cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Kaplan Meir curve for overall survival.
See this image and copyright information in PMC

References

    1. Mostofi F.K. Proceedings: Testicular tumors. Epidemiologic, etiologic, and pathologic features. Cancer. 1973;32:1186–1201. doi: 10.1002/1097-0142(197311)32:5<1186::AID-CNCR2820320527>3.0.CO;2-8. - DOI - PubMed
    1. Albers P., Albrecht W., Algaba F., Bokemeyer C., Cohn-Cedermark G., Fizazi K., Horwich A., Laguna M.P., Nicolai N., Oldenburg J. Guidelines on Testicular Cancer: 2015 Update. Eur Urol. 2015;68:1054–1068. doi: 10.1016/j.eururo.2015.07.044. - DOI - PubMed
    1. Chung P., Warde P. Testicular cancer: Germ cell tumours. BMJ Clin. Evid. 2016;2016:1807. - PMC - PubMed
    1. Ruf C.G., Isbarn H., Wagner W., Fisch M., Matthies C., Dieckmann K.P. Changes in epidemiologic features of testicular germ cell cancer: Age at diagnosis and relative frequency of seminoma are constantly and significantly increasing. Urol. Oncol. Semin. Orig. Investig. 2014;32:33.e1–33.e6. doi: 10.1016/j.urolonc.2012.12.002. - DOI - PubMed
    1. International Germ Cell Cancer Collaborative Group International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers. J. Clin. Oncol. 1997;15:594–603. doi: 10.1200/JCO.1997.15.2.594. - DOI - PubMed

LinkOut - more resources